Chemed Corporation to Present at JMP Securities Research Conference
CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (NYS: CHE) today announced that it will deliver a presentation at the 12th Annual JMP Securities Research Conference on May 13, 2013, at approximately 10:00 a.m. (PDT) at The Ritz-Carlton in San Francisco.
The presentation will be webcast live and can be accessed through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance.Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements.Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
Sherri L. Warner, 513-762-6683
KEYWORDS: United States North America California Ohio
The article Chemed Corporation to Present at JMP Securities Research Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.